Laura Katz: Is Human Lactoferrin Better Than Bovine Lactoferrin?
Laura Katz, Founder and CEO at Helaina, shared a post on LinkedIn:
“A pregnant woman with iron-deficiency anemia. A malnourished toddler.
A premature infant in the NICU, too small to make enough of his own.
A new mother whose milk hasn’t come in yet. A woman in perimenopause whose body is quietly falling apart.
An athlete who trains so hard her period stops.
These people need the healing powers of human lactoferrin.
Lactoferrin is important because it pumps through our veins.
Its a building block of our brain, gut, mouth, nose, skin and most importantly in world’s most precious food – mothers milk.
Making the version designed for cows takes the path of least resistance.
While we welcome competitors in producing human lactoferrin to bring this incredibly important ingredient to the world, anyone working on cows lactoferrin is wasting their time and anyone thinking it’s the same is being fooled.
The privilege that we have with precision fermentation technology is that we can replicate the best version of things.
Novo Nordisk pioneered human insulin. Once the human version was possible, nobody defended the pig version as ‘good enough.’
We’ve run the studies.
50mg of our effera human lactoferrin outperformed 500mg of cows lactoferrin. That’s ten times the dose.
Cows lactoferrin already exists, go license it from anyone selling milk byproducts.
We didn’t, because a starving child doesn’t have time for the easy answer.
We’ve spent years, with out team routinely in the lab at 2am, building the human protein instead of settling for the animal one.
Effera is human lactoferrin.
Made by fermentation.
Priced to make ‘good enough’ obsolete.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient